Navigation Links
Mount Sinai receives $3.4 million for largest study of personalized medicine in the clinical setting
Date:8/18/2011

00 patients from the Mount Sinai Biobank, which consists of consented patients representing the diverse communities surrounding The Mount Sinai Medical Center.

"This grant is a significant achievement for Mount Sinai, propelling us to the forefront of personalized medicine and its application in the clinical setting," said Dennis. S. Charney, MD, Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs of The Mount Sinai Medical Center. "The future of medicine lies in genomics research and translating it into a patient-care setting. Mount Sinai's commitment to translational research makes us uniquely poised to lead that revolution."

Mount Sinai Biobank patients have provided DNA and plasma samples to aid in genomic and personalized medicine research, allowing Dr. Bottinger's team to validate and customize 288 previously-reported single nucleotide polymorphisms (SNPs) as genetic risk markers of major diseases, including heart, kidney, and liver disease, for Mount Sinai's racially and ethnically diverse patient populations. The IPM team is committed to ensuring that this information is made available in culturally appropriate, easy to understand formats, and will have the potential to benefit all patients.

The IPM research team will create a Biobank database that will have each of these individual's genetic-disease risk profiles for heart, kidney, and liver disease, as well as their likely response to different medications and potential side effects data that will be entered into Mount Sinai's electronic medical record system for patients who consent to participate in this new study.

The study will include one group of physicians and patients that will be randomized to a genomic-risk assessment, and another that will be randomized to a traditional risk assessment, using risk factors like cholesterol and high blood pressure when determining a patient's risk for heart disea
'/>"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Guam researcher studies Mount Pinatubo ecosystem recovery
2. Pearl-flowered legume a surprise new find in the Cape Snowy Mountains, South Africa
3. Mount Sinai researchers develop new gene therapy for heart failure
4. Large numbers of birth defects seen near mountaintop mining operations
5. Mountain pine beetle activity may impact snow accumulation and melt, says CU-Boulder study
6. Mountain pine beetle marching east from Alberta
7. Human virus linked to deaths of endangered mountain gorillas
8. UCLA researchers engineer E. coli to produce record-setting amounts of alternative fuel
9. Recipe for family mealtimes calls for 3 ingredients in the right amounts
10. Islands in the sky: How isolated are mountain top plant populations?
11. New method will triple amount of genetic information from newborn blood spot screenings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Arizona State University, the Wellcome Trust Sanger Institute and ... isolated Mycobacterium pinnipedii from skeletons found in ... pathogen is a relative of the TB bacterium that ... today. These researchers assume that seals carried the pathogens ... sea lions was unexpected" comments Sebastien Gagneux, from the ...
(Date:8/20/2014)... Multiple fires are visible in in this image of ... Many of these were most likely intentionally set in ... of a forest or stand of trees where the ... of deforestation include conversion of forestland to farms, ranches, ... the dark green of the Amazon Rainforest in the ...
(Date:8/20/2014)... population-based screening outcomes of approximately 3 million infants, a ... at the University of Massachusetts Medical School, have shown ... be successfully implemented across public health newborn screening programs. ... Aug. 20 issue of the Journal of the ... rate of SCID in newborns is higher than previously ...
Breaking Biology News(10 mins):Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3
... Source of Salmonella Contamination on Pig Farms Commercial ... commercial swine production units, according to a paper in the ... Microbiology . Moreover, nearly half of isolates found in pigs ... a source of human infection. They also strongly question the ...
... from the University of California, San Diego have ... they created an artificial environment for stem ... electrical cues necessary for stem cell growth and ... is critical for realizing the promises of stem-cell-based ...
... acoustics (the "science of sound") have over the years developed ... oceans. This week, many of these acoustic researchers will come ... April,s Deepwater Horizon oil spill, to present new data on ... development that could improve our ability to detect oil in ...
Cached Biology News:Tips from the journals of the American Society for Microbiology 2Tips from the journals of the American Society for Microbiology 3Tips from the journals of the American Society for Microbiology 4Tips from the journals of the American Society for Microbiology 5Tips from the journals of the American Society for Microbiology 6Bioengineers provide adult stem cells with simultaneous chemical, electrical and mechanical cues 2Bioengineers provide adult stem cells with simultaneous chemical, electrical and mechanical cues 3Bioengineers provide adult stem cells with simultaneous chemical, electrical and mechanical cues 4Listening for ocean spills and their ecological effects 2Listening for ocean spills and their ecological effects 3
(Date:8/19/2014)... Research and Markets  has announced the addition of ... Report" report to their offering. This report ... US$ Thousands by the following Product Segments: Media, Sera, and Reagents. ... Canada , Japan , ... Latin America . Annual estimates and forecasts are provided ...
(Date:8/19/2014)... 19, 2014 XenoTech announces an ... cost-effective metabolite production from bioactive small molecules. ... the technology enables convenient and timely assessment of ... XenoTech’s Vice President of Commercial Operations, Christian Darabant, ... clinical risk can be measured directly by comparison ...
(Date:8/19/2014)... Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" ... reported results of its Oral Amphotericin B (Oral ... The study, conducted by ImmuneCarta®, the immune monitoring ... effectiveness of Oral Amp B in reactivating ... individuals despite intensive treatment with antiretroviral therapy. ...
(Date:8/18/2014)... 18, 2014 BioElectronics Corporation (OTC ... medical devices said that its EVP Dr. ... CEOLIVE.TV as part of its Executive Interview ... available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... investors the unique advantages of BioElectronics patented ...
Breaking Biology Technology:Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3
... (Nasdaq: MNKD ), focused on discovering, developing and,commercializing ... present at the Wachovia Healthcare Conference on January 30, ... Boston, MA., Interested parties can access a link ... Investor Relations section of the Company,s website at, http://www.mannkindcorp.com ...
... a biotechnology company discovering and developing the next wave of,antibody therapeutics, today ... year end 2007 results at 8:00 a.m. (Eastern,Time) on Tuesday, January 29, ... issued at 7:00 a.m. prior to the call., DATE: ... Tuesday, January 29, 2008, TIME: ...
... Jan. 25 AMDL, Inc. (Amex:,ADL), headquartered ... and Jilin China, through its wholly owned ... company that, together,with Jade, engages in the ... care and diagnostic products. It today,announced that ...
Cached Biology Technology:ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call 2AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000 2